94 related articles for article (PubMed ID: 1633108)
1. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent.
Warner GL; Ludlow JW; Nelson DA; Gaur A; Scott DW
Cell Growth Differ; 1992 Mar; 3(3):175-81. PubMed ID: 1633108
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1.
Joseph LF; Ezhevsky S; Scott DW
Cell Growth Differ; 1995 Jan; 6(1):51-7. PubMed ID: 7718485
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.
Münger K; Pietenpol JA; Pittelkow MR; Holt JT; Moses HL
Cell Growth Differ; 1992 May; 3(5):291-8. PubMed ID: 1633111
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta 1 inhibits DNA synthesis and phosphorylation of the retinoblastoma gene product in a rat liver epithelial cell line.
Whitson RH; Itakura K
J Cell Biochem; 1992 Mar; 48(3):305-15. PubMed ID: 1400615
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 (TGF-beta 1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-beta 1-growth stimulated colon carcinoma cells.
Yan Z; Hsu S; Winawer S; Friedman E
Oncogene; 1992 Apr; 7(4):801-5. PubMed ID: 1565477
[TBL] [Abstract][Full Text] [Related]
6. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
7. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
Santos-Argumedo L; Gordon J; Heath AW; Howard M
Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
[TBL] [Abstract][Full Text] [Related]
9. TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.
Moses HL; Pietenpol JA; Münger K; Murphy CS; Yang EY
Princess Takamatsu Symp; 1991; 22():183-95. PubMed ID: 1844240
[TBL] [Abstract][Full Text] [Related]
10. Loss of transforming growth factor beta 1 regulatory activity in human non Hodgkin lymphomas.
Kopper L; Ladanyi A; Mihalik R; Nagy P
Anticancer Res; 1994; 14(1A):119-22. PubMed ID: 8166437
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
Snapper CM; Waegell W; Beernink H; Dasch JR
J Immunol; 1993 Nov; 151(9):4625-36. PubMed ID: 8409423
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
[TBL] [Abstract][Full Text] [Related]
14. Media acidification inhibits TGF beta-mediated growth suppression in cultured rabbit proximal tubule cells.
Tovbin D; Franch HA; Alpern RJ; Preisig PA
Proc Assoc Am Physicians; 1997 Nov; 109(6):572-9. PubMed ID: 9394419
[TBL] [Abstract][Full Text] [Related]
15. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas.
Hasbold J; Klaus GG
Eur J Immunol; 1990 Aug; 20(8):1685-90. PubMed ID: 2209683
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
18. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
Scott DW; O'Garra A; Warren D; Klaus GG
J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
[TBL] [Abstract][Full Text] [Related]
19. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
Satterwhite DJ; White RL; Matsunami N; Neufeld KL
Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]